Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Southwest Airlines Co
LUV
Industrials
Airlines
Southwest Airlines Co. (Southwest) operates Southwest Airlines, a passenger airline that provides scheduled air transportation in the United States and near-international markets. The Company's fare products include four categories: Wanna Get Away, Wanna Get Away Plus, Anytime, and Business Select to provide customers options when choosing a fare. It offers ancillary services, such as EarlyBird...
Check-In, Upgraded Boarding, and transportation of pets and unaccompanied minors, in accordance with Southwest’s respective policies. EarlyBird Check-In provides customers with automatic check-in and an assigned boarding position before general boarding positions become available. It has over 817 Boeing 737 aircraft in its fleet and serves 121 destinations in 42 states, the District of Columbia, the Commonwealth of Puerto Rico, and ten near-international countries: Mexico, Jamaica, The Bahamas, Aruba, Dominican Republic, Costa Rica, Belize, Cuba, the Cayman Islands, and Turks and Caicos.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:LUV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(83)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 25, 2024 9:45pm
Southwest Airlines (LUV) Q1 2024 Earnings Call Transcript
News; $LUV Southwest Airlines (LUV) Q1 2024 Earnings Call Transcript2024-04-25 19:45:21 ET Image source: The Motley Fool. Southwest Airlines (NYSE: LUV) Q1 2024 Earnings Call Apr 25, 2024 , 12:30 p.m.
...more
(123)
•••
TELEMARKER
X
View Profile
View Bullboard History
Post by
TELEMARKER
on Dec 18, 2023 8:20pm
December 18
Southwest Airlines reaches $140 million settlement over holiday flight-canceling meltdown last year (msn.com)
Fresh Insight into the Topaz Helium Project's Expected Size and Scale
posted Apr 26, 2024 9:00am by
Pulsar Helium Inc.
-
|
The prospective zone is very broad. We believe its not just an isolated occurrence but is actually something quite regionally extensive ...read more
(0)
•••
Peng26
X
View Profile
View Bullboard History
Post by
Peng26
on Apr 13, 2023 4:08am
This is the very exciting part! A breakthrough product!
This is Going to Change Society: Kevin Harrington Speaks about FSD Pharma{^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com/watch?v=GTz2294l4KA|(fs)True|(loop)False
...more
(0)
•••
TaylorSwifft
X
View Profile
View Bullboard History
Post by
TaylorSwifft
on Apr 13, 2023 2:53am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(1)
•••
Contra_Man
X
View Profile
View Bullboard History
Comment by
Contra_Man
on Feb 02, 2023 10:18am
RE:RE:Domestic Travel Surge
Exited LUV-N @ $35.75 to now hold NIL.
(1)
•••
Contra_Man
X
View Profile
View Bullboard History
Comment by
Contra_Man
on Dec 28, 2022 4:07pm
RE:Domestic Travel Surge
@ $32.19 :P
(1)
•••
Contra_Man
X
View Profile
View Bullboard History
Post by
Contra_Man
on Dec 28, 2022 4:05pm
Domestic Travel Surge
Added fifteen (15) LUV-N positions @ $139.96 to now hold 15/15 inventory allocation.
(0)
•••
TaylorSwifft
X
View Profile
View Bullboard History
Post by
TaylorSwifft
on Jul 14, 2022 1:25am
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(0)
•••
TaylorSwifft
X
View Profile
View Bullboard History
Post by
TaylorSwifft
on Jun 03, 2022 3:58am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
(0)
•••
TaylorSwifft
X
View Profile
View Bullboard History
Post by
TaylorSwifft
on Jun 01, 2022 11:18pm
FSD Pharma Files Investigational New Drug Application “IND”
(0)
•••
TaylorSwifft
X
View Profile
View Bullboard History
Post by
TaylorSwifft
on May 10, 2022 11:32pm
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(0)
•••
TaylorSwifft
X
View Profile
View Bullboard History
Post by
TaylorSwifft
on Apr 30, 2022 2:29am
Lucid-MS for Multiple Sclerosis Treatment
(0)
•••
TaylorSwifft
X
View Profile
View Bullboard History
Post by
TaylorSwifft
on Apr 21, 2022 11:54pm
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(0)
•••
TaylorSwifft
X
View Profile
View Bullboard History
Post by
TaylorSwifft
on Apr 15, 2022 8:46am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(0)
•••
TaylorSwifft
X
View Profile
View Bullboard History
Post by
TaylorSwifft
on Apr 09, 2022 12:37am
FSD: Cancellation of Certain Shares Issued to Former CEO
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale
Exploration company provides project portfolio update
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil